Author:
Jiang Jun-Xia,Cao Rui,Deng Wan-Ding,Jin Fang,Dong Xin-Wei,Zhu Yu,Chen Xiao-Ping,Xie Yi-Cheng,Bao Meng-Jing,Li Fen-Fen,Xie Qiang-Min
Reference49 articles.
1. Some quantitative uses of drug antagonists;Arunlakshana;Br. J. Pharmacol.,1959
2. The role of anticholinergics in chronic obstructive pulmonary disease;Barnes;Am. J. Med.,2004
3. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease;Belmonte;Proc. Am. Thorac. Soc.,2005
4. Pharmacological control of thromboxane A2 in lung;Berti;Bull. Eur. Physiopathol. Respir.,1981
5. Summary of the recommendations of the Canadian Consensus Conference on Asthma 1999. Canadian Asthma Consensus Group;Bolulet;C.M.A.J.,1999
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structure, function and drug discovery of GPCR signaling;Molecular Biomedicine;2023-12-04
2. Synthesis, Characterization, and Application of Muscarinergic M3 Receptor Ligands Linked to Fluorescent Dyes;Journal of Medicinal Chemistry;2022-12-09
3. Safety, Tolerability and Pharmacokinetics of Bencycloquidium Bromide, a Novel Inhaled Anticholinergic Bronchodilator, in Healthy Subjects: Results from Phase I Studies;European Journal of Pharmaceutical Sciences;2021-02
4. Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
;Journal of Experimental Pharmacology;2020-12
5. Bencycloquidium bromide nasal spray is effective and safe for persistent allergic rhinitis: a phase III, multicenter, randomized, double-blinded, placebo-controlled clinical trial;European Archives of Oto-Rhino-Laryngology;2020-07-04